A

Akido

AI-powered healthcare platform for scalable care

Advanced Practice Pharmacist

Full-TimeUpdated on 10/23/2026
$150k - $170k+ Stock options
Mid
PharmD
California, USA
In Person
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • A Doctor of Pharmacy (PharmD) degree from an accredited college or school of pharmacy.
  • A current and unrestricted pharmacist license in the applicable state.
  • Advanced Practice Pharmacist designation or eligibility in accordance with California regulations.
  • A minimum of two years of clinical pharmacy experience in ambulatory care, primary care, managed care, or related settings.
  • Strong knowledge of chronic disease state management and evidence-based treatment guidelines.
  • Experience utilizing electronic health records and clinical documentation systems.
  • Ability to manage multiple priorities while maintaining high-quality patient care and service.
Responsibilities
  • Provide comprehensive medication management services for patients with chronic and complex medical conditions.
  • Evaluate and optimize medication regimens in accordance with evidence-based guidelines and organizational protocols.
  • Initiate, modify, monitor, and discontinue medications pursuant to applicable regulations and collaborative practice agreements.
  • Conduct patient assessments and medication reviews to identify drug therapy problems and opportunities for improved outcomes.
  • Monitor therapeutic effectiveness, adverse drug reactions, medication adherence, and patient safety concerns.
  • Collaborate with physicians and interdisciplinary teams to develop individualized treatment plans.
  • Provide patient counseling and education regarding medications, disease states, treatment goals, and self-management strategies.
  • Document clinical interventions, patient encounters, and medication recommendations within the electronic health record.
  • Participate in quality improvement initiatives designed to improve clinical performance and patient outcomes.
  • Support population health programs focused on chronic disease management, preventive care, and medication optimization.
Desired Qualifications
  • Completion of a Pharmacy Practice Residency (PGY1) or equivalent clinical experience.

About the company

Akido Labs uses artificial intelligence to improve access to high-quality, personalized medical care by connecting providers with an extensive medical network and offering scalable AI-powered tools. Its platform works by integrating AI with the healthcare network to help primary care physicians and specialists expand patient capacity, improve outcomes, and tailor care. It also identifies household-level outbreaks and targets treatments and vaccines where they are most needed, helping to prevent future pandemics. The company differentiates itself through a strong emphasis on empathy, equity, and global access, aiming to bridge advanced medical technology with accessible care and partnering with healthcare providers to scale solutions. Akido Labs’ goal is to make excellent healthcare a basic human right by enabling faster access to care, better outcomes, and proactive public health interventions on a global scale.

Company Size

51-200

Company Stage

Series B

Total Funding

$66.3M

Headquarters

West Hollywood, California

Founded

2015

Get referred to Akido

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Akido said July 30, 2026 revenue grew 300% from 2024 to 2025.
  • The January 28, 2026 Bay Area program put ScopeAI into urgent street-medicine workflows.
  • Oak HC/FT's $60 million Series B funds 2025-2026 expansion and new market entry.

What critics are saying

  • Guardian criticism on January 25, 2026 targets AI diagnosis for low-income patients.
  • CalMatters on January 27, 2026 flagged privacy, bias, and reliability risks in homeless care.
  • If ScopeAI causes a serious adverse event, Medicaid scrutiny can freeze expansion quickly.

What makes Akido unique

  • ScopeAI runs visits across 100 clinics and 1 million covered lives in 2026.
  • Akido combines owned provider network, virtual care, and street medicine into one system.
  • Clinical leadership includes Matt Rothstein, Cambron Carter, and an AI Clinical Advisory Council.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Paid Sick Leave
  • Paid Vacation
  • 401(k) Retirement Plan
  • Hybrid Work Options
  • Remote Work Options
  • Wellness Program

Growth & Insights and Company News

6 month growth

16%

1 year growth

9%

2 year growth

3%
PR Newswire
Jul 30th, 2026
Akido builds first AI-native US health system serving 1M patients across California, New York, and Rhode Island

Akido has announced it is building the first AI-native health system in the US, deploying its ScopeAI technology across 100 clinics and serving 1 million patients in California, New York City, and Rhode Island. The platform organises clinical information in real time, allowing physicians to focus on patient care rather than administration. The company's revenue grew by 300% between 2024 and 2025. ScopeAI has been tested against 203,000 clinical encounters and delivers a Net Promoter Score of 96. Akido is dropping "Labs" from its name and launching Akido Medical as its clinical brand. The company has appointed Matt Rothstein as vice president of engineering and Cambron Carter as principal AI architect. It has also established an AI Clinical Advisory Council to oversee its systems.

Associated Press
Jan 28th, 2026
Bay Area launches first AI-powered safety net programme for unhoused communities

Future Communities Institute has launched the Bay Area's first AI-powered safety net programme in partnership with Five Keys, ReImagine Freedom and Akido Labs. The initiative will use Akido's AI-enabled care model to expand street medicine teams and deliver personalised care to vulnerable populations. The programme addresses growing homelessness in the Bay Area, which has increased 6% year-over-year, with approximately two-thirds of unhoused residents living on the streets. It deploys Akido's ScopeAI system, which guides community health workers through comprehensive patient visits and can initiate medically assisted treatment for substance use disorders within four hours of initial contact. ScopeAI has been trained on over 10 million patient cases and currently supports visits across multiple medical specialties, serving 500,000 patients through Akido's network of 240 clinicians.

PR Newswire
Jan 22nd, 2026
Akido Labs appoints Matt Siegler as chief network officer with 500K+ patients across 3 US states

Akido Labs has appointed Matt Siegler as Chief Network Officer to lead growth and operations across its AI-powered care network serving over 500,000 patients in California, Rhode Island and New York. Siegler previously served as Chief Growth and Strategy Officer at NYC Health & Hospitals, where he drove $6 billion in revenue growth. The company also added Jack Greco, co-founder of $3 billion ACV Auctions, to its board of directors. Cath Anderson joined as Chief Communications Officer, whilst Jim McGee moved into the role of Chief Transformation Officer. The appointments come as Akido reports 300% year-over-year revenue growth into the mid-nine figures. The AI-native healthcare provider operates across 26 specialties and plans rapid expansion in 2026, scaling its risk-bearing care models and ScopeAI clinical platform.

PRWeek
Sep 8th, 2025
Akido Labs hires Catherine Anderson as first chief communications officer

LOS ANGELES: Healthcare technology company Akido Labs has hired Catherine Anderson as chief communications officer, effective Monday.

Wow Partners, Inc.
May 25th, 2025
Akido Labs Raises $60M Series B Funding

Akido Labs, an AI healthcare company, has secured a $60 million Series B funding round led by Oak HC/FT, with participation from Greco, SNR, Y Combinator, Future Communities Capital, and Google's Jeff Dean. The funds will be used to expand the AI system 'ScopeAI', which enhances clinical capabilities and improves healthcare accessibility. ScopeAI allows medical staff to manage more patients without compromising quality, addressing the gap in the U.S. healthcare system's capacity.